Laboratory Investigation Report: 32 Years/M 1222956254

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

Laboratory Investigation Report

PHD No. : 1PHD3394071 Age/Gender : 32 Years/M Sample No. : 1222956254


Name : CHAMINDA HIROSHAN SEMBAKUTTI ARACHCHIGE Collection Date : 12/07/2022 19:00
Doctor : Self Patient Received Date : 13/07/2022 01:29
Centre : American European Medical Center Ref No. : PHDC00085907 Reporting Date : 13/07/2022 06:19
COVID Emirates ID : 784-1989-0387290-5

MOLECULAR MICROBIOLOGY
SARS-CoV-2 (Covid-19)
Test / Parameters Result Units Reference Range Methodology
Genes Screened RealTime PCR

ORF 1 ab / RdRp Negative Negative


N-GENE Negative Negative

RESULT
SARS-CoV-2 Not-Detected Not-Detected
Sample Type : Nasopharyngeal Swab

Routine confirmation of cases of COVID-19 is based on detection of unique sequences of virus RNA by NAAT.
Real-time reverse-transcription polymerase chain reaction (rRT-PCR) iis used to test for virus specific genes.
.
Confirmation by nucleic acid sequencing should be done when necessary.
One or more negative results do not rule out the possibility of COVID-19 virus infection.
A number of factors could lead to a negative result in an infected individual, including:
- poor quality of the specimen, containing little patient material (as a control, consider
determining whether there is adequate human DNA in the sample by including a human target
in the PCR testing)
- the specimen was collected late or very early in the infection
- the specimen was not handled and shipped appropriately
- technical reasons inherent in the test, e.g. virus mutation or PCR inhibition.

If a negative result is obtained from a patient with a high index of suspicion for COVID-19 virus infection,
particularly when only upper respiratory tract specimens were collected, additional specimens, including
from the lower respiratory tract if possible, should be collected and tested.

Reference: Laboratory testing for coronavirus disease 2019( COVID-19) in suspected human cases.
WHO interim guidance 2 March 2020

This test was performed at a CAP & EIAC (ISO 15189) accredited referral lab but test is not currently included in the scope and being processed under
Emergency Use Authorization(EUA)

COVID-19 test has been performed in the Emirate of Abu Dhabi


*** End Of Report ***

For any report-related concern, please contact us through:


Hotline: +971 2 491 9300
Mobile: +971 50 312 4035
EMAIL: phdcovid@proficiencylab.org Dr. Panna P Shetty
Specialist Anatomic and Clinical Pathologist , GD24436

Final Report Page 1 of 1 Uploaded Date/Time : 13/07/2022 06:27AM

Abu Dhabi | Al ain | Dubai | Sharjah www.phd-laboratories.com

You might also like